Brief: Avalon Globocare Announces Mesenchymal Stromal Cell Therapeutic Platform For Covid-19 And Acute Graft Versus Host Disease

Change Agents

03/09/2020 14:41

Sept 3 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE ANNOUNCES MESENCHYMAL STROMAL CELL
THERAPEUTIC
PLATFORM FOR COVID-19 AND ACUTE GRAFT VERSUS HOST DISEASE
(AGVHD)
    * AVALON GLOBOCARE CORP - CURRENTLY PROGRESSING PLANNED
PRE-CLINICAL TESTING FOR MSC THERAPEUTIC PLATFORM FOR COVID-19
AND AGVHD
    * AVALON GLOBOCARE CORP - PLANS TO INITIATE FIRST-IN-HUMAN
CLINICAL STUDY OF MSC THERAPEUTIC PLATFORM DURING FIRST HALF OF
2021

Source text for Eikon:  ID:nGNX4nn5qf 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))